Haoxi Health Technology L... (HAO)
Haoxi Health Technology Statistics
Share Statistics
Haoxi Health Technology has 19.4M shares outstanding. The number of shares has increased by -34.63% in one year.
| Shares Outstanding | 19.4M |
| Shares Change (YoY) | -34.63% |
| Shares Change (QoQ) | -39.68% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 16.91M |
| Failed to Deliver (FTD) Shares | 772 |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 68.04K, so 2.41% of the outstanding shares have been sold short.
| Short Interest | 68.04K |
| Short % of Shares Out | 2.41% |
| Short % of Float | 4% |
| Short Ratio (days to cover) | 1.95 |
Valuation Ratios
The PE ratio is 3038.28 and the forward PE ratio is null. Haoxi Health Technology's PEG ratio is 78.27.
| PE Ratio | 3038.28 |
| Forward PE | n/a |
| PS Ratio | 80.88 |
| Forward PS | null |
| PB Ratio | 348.16 |
| P/FCF Ratio | -4887.58 |
| PEG Ratio | 78.27 |
Enterprise Valuation
Haoxi Health Technology has an Enterprise Value (EV) of 3.92B.
| EV / Sales | 80.77 |
| EV / EBITDA | 2193.06 |
| EV / EBIT | -5242.27 |
| EV / FCF | -4880.79 |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.98 |
| Quick Ratio | 3.98 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | -1.5 |
| Interest Coverage | 41.69 |
Financial Efficiency
Return on Equity is 11.46% and Return on Invested Capital is 10.29%.
| Return on Equity | 11.46% |
| Return on Assets | 8.33% |
| Return on Invested Capital | 10.29% |
| Revenue Per Employee | $1.62M |
| Profits Per Employee | $43.06K |
| Employee Count | 30 |
| Asset Turnover | 3.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 443.58K |
| Effective Tax Rate | 25.56% |
Stock Price Statistics
The stock price has increased by -99.05% in the last 52 weeks. The beta is -1.65, so Haoxi Health Technology's price volatility has been lower than the market average.
| Beta | -1.65 |
| 52-Week Price Change | -99.05% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 30.95 |
| Relative Strength Index (RSI) | 40.25 |
| Average Volume (20 Days) | 307.05K |
Income Statement
In the last 12 months, Haoxi Health Technology had revenue of 48.52M and earned 1.29M in profits. Earnings per share was 0.04.
| Revenue | 48.52M |
| Gross Profit | 2.75M |
| Operating Income | 1.72M |
| Net Income | 1.29M |
| EBITDA | 1.79M |
| EBIT | 1.78M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 6.66M in cash and 1.2M in debt, giving a net cash position of 5.45M.
| Cash & Cash Equivalents | 6.66M |
| Total Debt | 1.2M |
| Net Cash | 5.45M |
| Retained Earnings | 723.21K |
| Total Assets | 15.51M |
| Working Capital | 11.51M |
Cash Flow
In the last 12 months, operating cash flow was -747.58K and capital expenditures -55.37K, giving a free cash flow of -802.94K.
| Operating Cash Flow | -747.58K |
| Capital Expenditures | -55.37K |
| Free Cash Flow | -802.94K |
| FCF Per Share | -0.03 |
Margins
Gross margin is 5.67%, with operating and profit margins of 3.54% and 2.66%.
| Gross Margin | 5.67% |
| Operating Margin | 3.54% |
| Pretax Margin | 3.58% |
| Profit Margin | 2.66% |
| EBITDA Margin | 3.68% |
| EBIT Margin | 3.54% |
| FCF Margin | -1.65% |
Dividends & Yields
HAO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0.03% |
| FCF Yield | -0.02% |
Analyst Forecast
Currently there are no analyst rating for HAO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 27, 2025. It was a backward split with a ratio of 1:25.
| Last Split Date | Jan 27, 2025 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | 10.39 |
| Piotroski F-Score | 5 |